These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14023830)

  • 1. [Plasma transfusion in hemophilia. VIII. Effect of various plasma products on hemophilia A].
    van CREVELD ; MOCHTAR IA
    Ned Tijdschr Geneeskd; 1963 Jan; 107():155-9. PubMed ID: 14023830
    [No Abstract]   [Full Text] [Related]  

  • 2. [HEMOSTATIC TRANSFUSION PREPARATIONS PREPARED FROM DONOR BLOOD (ANTIHEMOPHILIC PLASMA, ANTIHEMOPHILIC GLOBULIN, FIBRINOGEN)].
    ROZENBERG GIa; RUDNITSKAIA MZ
    Probl Gematol Pereliv Krovi; 1963 Jun; 8():3-9. PubMed ID: 14070543
    [No Abstract]   [Full Text] [Related]  

  • 3. [PLASMA TRANSFUSION IN HEMOPHILIA. IX. EXPERIENCE WITH 2-DONOR FIBRINOGEN].
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Ned Tijdschr Geneeskd; 1963 Sep; 107():1736-9. PubMed ID: 14050958
    [No Abstract]   [Full Text] [Related]  

  • 4. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. II.
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1963 Nov; 89(18):911-4. PubMed ID: 14052972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PLASMA TRANSFUSIONS IN HEMOPHILIA (X). EXPERIENCES WITH LYOPHILIZED 2-DONOR FIBRINOGEN].
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Ned Tijdschr Geneeskd; 1964 Apr; 108():843-4. PubMed ID: 14144908
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE SUPPLY OF PERSONALLY PREPARED PLASMA FRACTIONS IN HEMOPHILIA A].
    GAERISCH F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 81():148-55. PubMed ID: 14165084
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of classic hemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery.
    MCMILLAN CW; DIAMOND LK; SURGENOR DM
    N Engl J Med; 1961 Aug; 265():277-83 concl. PubMed ID: 13774141
    [No Abstract]   [Full Text] [Related]  

  • 8. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. III.
    VANCREVELD S; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1964 May; 90(22):1248-9. PubMed ID: 14158954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ANOMALOUS BEHAVIOR OF HAEMOPHILIA A FIBRINOGEN DURING ULTRACENTRIFUGATION.
    BLOMBAECK B; BLOMBAECK M; LAURENT TC; PERSSON H
    Biochim Biophys Acta; 1965 Jan; 97():171-3. PubMed ID: 14284312
    [No Abstract]   [Full Text] [Related]  

  • 10. [Substitution therapy of hemorrhagic diseases].
    Haupt H
    Anasthesiol Intensivmed Prax; 1975 Oct; 11(1):137-44. PubMed ID: 1225069
    [No Abstract]   [Full Text] [Related]  

  • 11. The safe blood components for a hemophilia patient: a case report.
    Chuansumrit A; Pandhawong S; Tardtong P; Isarangkura P
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():198-200. PubMed ID: 7886573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of blood products and factor concentrates for coagulation therapy.
    Fritsma MG
    Clin Lab Sci; 2003; 16(2):115-9. PubMed ID: 12757192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy reviews: clinical use of hemostatic agents.
    Lowe GD; Lawson DH
    Am J Hosp Pharm; 1978 Apr; 35(4):414-22. PubMed ID: 306196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TECHNIC OF TRANSFUSION THERAPY IN SURGERY ON HEMOPHILIACS].
    ABDULLAEV GM; KOZHEVNIKOV IN
    Probl Gematol Pereliv Krovi; 1964 Aug; 9():36-40. PubMed ID: 14252414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principles of using blood preparation in children with hemophilia and other congenital hemorrhagic disorders].
    Adamowicz-Salach A; Kamińskka D; Jakubowska M; Gregosiewicz A; Rokicka-Milewska R
    Pediatr Pol; 1988 May; 63(5):273-8. PubMed ID: 3146055
    [No Abstract]   [Full Text] [Related]  

  • 16. [EXPERIMENTS CONCERNING FACTOR 8. LONGEVITY OF FACTOR 8 IN VIVO AND VITRO AND THE SUBFRACTIONATION OF FIBRINOGEN SAMPLES FROM 2 DONORS].
    MOCHTAR IA; KOPPE JG; STIBBE J
    Maandschr Kindergeneeskd; 1964 Jul; 32():440-5. PubMed ID: 14228685
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of hemophilia and its social aspects].
    Digilio G
    Minerva Pediatr; 1967 Nov; 19(44):1963-9. PubMed ID: 5616636
    [No Abstract]   [Full Text] [Related]  

  • 18. [Spontaneous splenic rupture in a child with hemophilia].
    Gruminskiĭ VS; Grechanyĭ VP
    Vestn Khir Im I I Grek; 1990 Apr; 144(4):69-70. PubMed ID: 2173236
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various methods for good blood supply in Scandinavia].
    Oldinger E
    Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of in vivo analysis of injected fibrinogen degradation products and factor VIII in patients with hemophilia A].
    Kätzel R; Kubel M; Scheel H; Wegner H
    Z Gesamte Inn Med; 1978 Aug; 33(15):525-9. PubMed ID: 695793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.